Lista de obras - Luca Prosperini - Dominio Público Uruguay

'Posture second' strategy predicts disability progression in multiple sclerosis

artículo científico publicado en 2020

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

artículo científico publicado en 2018

Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.

artículo científico publicado en 2017

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression

artículo científico publicado en 2020

Assessing response to interferon-β in a multicenter dataset of patients with MS.

artículo científico publicado en 2016

Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.

artículo científico publicado en 2013

Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis

artículo científico publicado en 2013

Balance worsening associated with nabiximols in multiple sclerosis

artículo científico publicado en 2018

Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS

scientific article published on 01 September 2019

Box and Block Test, Hand Grip Strength, and 9-Hole Peg Test: Correlations between Three Upper Limb Objective Measures in Multiple Sclerosis

artículo científico publicado en 2020

Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis

artículo científico publicado en 2019

Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial

scientific article published on 09 December 2019

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

scientific article published on 10 December 2020

Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study

artículo científico publicado en 2017

Determinants of the severity of comorbid migraine in multiple sclerosis.

artículo científico publicado en 2012

Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings.

artículo científico publicado en 2013

Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis

scientific article published on 01 April 2007

Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report

artículo científico publicado en 2018

Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study.

artículo científico publicado en 2011

Efficacy of early physical therapy in severe Bell's palsy: a randomized controlled trial.

artículo científico publicado en 2013

Emerging oral drugs for multiple sclerosis

artículo científico publicado en 2008

Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis ⬇️

artículo científico publicado el 9 de agosto de 2011

Examining the validity of the multiple-sclerosis walking scale-12 with Rasch analysis: Results from an Italian study

artículo científico publicado en 2019

Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression

artículo científico publicado en 2020

Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study

artículo científico publicado en 2019

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

artículo científico publicado en 2015

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

artículo científico publicado en 2014

Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosis.

artículo científico publicado en 2013

Interferon after 10 years in patients with multiple sclerosis.

artículo científico publicado en 2006

Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography

artículo científico publicado en 2015

Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.

artículo científico publicado en 2012

Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis

artículo científico publicado en 2016

MRI for monitoring response to preventive treatment in multiple sclerosis

artículo científico publicado en 2009

MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis.

artículo científico publicado en 2012

Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

artículo científico publicado en 2011

Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis

scientific article published on 23 January 2020

Mood and coping in clinically isolated syndrome and multiple sclerosis.

artículo científico publicado en 2013

Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome.

artículo científico publicado en 2011

Natalizumab treatment in pediatric multiple sclerosis: a case report

scientific article published on 11 April 2008

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

artículo científico publicado en 2016

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

scientific article published on 26 September 2018

Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case report

artículo científico publicado en 2019

Observations during an elective interruption of natalizumab treatment: a post-marketing study

artículo científico publicado en 2010

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

article

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

article

Predicting the profile of increasing disability in multiple sclerosis

scientific article published on 02 August 2018

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.

artículo científico publicado en 2012

Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis

scientific article published on 09 January 2020

Primary headache and multiple sclerosis: preliminary results of a prospective study

scientific article published on 01 May 2008

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

scientific article published on 07 November 2011

Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.

artículo científico publicado en 2016

Spotlight on postural control in patients with multiple sclerosis.

artículo científico publicado en 2018

The clinical relevance of force platform measures in multiple sclerosis: a review.

artículo científico publicado en 2013

The diagnostic accuracy of static posturography in predicting accidental falls in people with multiple sclerosis.

artículo científico publicado en 2012

The dual task-cost of standing balance affects quality of life in mildly disabled MS people

artículo científico publicado en 2016

The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis.

artículo científico publicado en 2012

The relationship between infratentorial lesions, balance deficit and accidental falls in multiple sclerosis.

artículo científico publicado en 2011

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

scientific article published on 17 September 2020

The use of ID migraine™ questionnaire in patients with multiple sclerosis

artículo científico publicado en 2010

Treating multiple sclerosis with fingolimod or intramuscular interferon.

artículo científico publicado en 2010

Unilateral meningitis: unusual central nervous system involvement in rheumatoid arthritis

artículo científico publicado en 2020

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

artículo científico publicado en 2018

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement

scientific article published on 17 September 2020

Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis

artículo científico publicado en 2010

Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study

artículo científico publicado en 2011

Lista de obras de Luca Prosperini

'Posture second' strategy predicts disability progression in multiple sclerosis

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression

Assessing response to interferon-β in a multicenter dataset of patients with MS.

Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.

Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis

Balance worsening associated with nabiximols in multiple sclerosis

Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS

Box and Block Test, Hand Grip Strength, and 9-Hole Peg Test: Correlations between Three Upper Limb Objective Measures in Multiple Sclerosis

Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis

Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study

Determinants of the severity of comorbid migraine in multiple sclerosis.

Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings.

Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis

Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report

Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study.

Efficacy of early physical therapy in severe Bell's palsy: a randomized controlled trial.

Emerging oral drugs for multiple sclerosis

Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis ⬇️

Examining the validity of the multiple-sclerosis walking scale-12 with Rasch analysis: Results from an Italian study

Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression

Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

Home-based balance training using the Wii balance board: a randomized, crossover pilot study in multiple sclerosis.

Interferon after 10 years in patients with multiple sclerosis.

Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography

Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.

Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis

MRI for monitoring response to preventive treatment in multiple sclerosis

MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis.

Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis

Mood and coping in clinically isolated syndrome and multiple sclerosis.

Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome.

Natalizumab treatment in pediatric multiple sclerosis: a case report

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case report

Observations during an elective interruption of natalizumab treatment: a post-marketing study

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

Predicting the profile of increasing disability in multiple sclerosis

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.

Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis

Primary headache and multiple sclerosis: preliminary results of a prospective study

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.

Spotlight on postural control in patients with multiple sclerosis.

The clinical relevance of force platform measures in multiple sclerosis: a review.

The diagnostic accuracy of static posturography in predicting accidental falls in people with multiple sclerosis.

The dual task-cost of standing balance affects quality of life in mildly disabled MS people

The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis.

The relationship between infratentorial lesions, balance deficit and accidental falls in multiple sclerosis.

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

The use of ID migraine™ questionnaire in patients with multiple sclerosis

Treating multiple sclerosis with fingolimod or intramuscular interferon.

Unilateral meningitis: unusual central nervous system involvement in rheumatoid arthritis

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement

Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis

Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study